ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

Centers Got $35 Million In NIH Construction $$; Send In Applications, Branch Chief Says

July 24, 1992